PMCPA Case Library

1,752 PMCPA Rulings.
Every One Analysed.

The only structured, searchable PMCPA case library in the UK. Expert video walkthroughs, podcast episodes, and MCQ assessments on every ruling — so you understand why companies breach the Code, not just that they did.

▶ Video analysis per case
🎧 Podcast per case
✍ MCQ + CPD certificate
🔒 From £299/year
1752+
Case Studies
5 min
Per Video
5 pts
Per Case Passed
8
Themes
📚
Subscribe for full case library access
Read free summaries below, or subscribe to unlock expert video walkthroughs, podcast audio and CPD certificates.
Sign in See plans ↓
Free — Browsing
✓ Browse all 1752+ case titles
✓ Filter by theme & therapy area
✓ See case reference, company & outcome
✗ Search by company or clause
✗ Video walkthroughs
✗ Podcast episodes
✗ MCQ assessments & CPD certificates
Subscribed — Full Access
✓ Search by company, clause & case ref
✓ Expert video walkthrough per case
✓ Podcast episode per case
✓ MCQ quiz — 5 CPD points per pass
✓ Personalised CPD completion certificate
✓ New cases added monthly
Subscribe from £299/year →
Search by company, clause, case reference... 🔒
All (1752) Social Media & Digital (720) HCP Hospitality & Meetings (431) Data & Publications (321) Off-label Promotion (219) Patient Organisations (44) Transfers of Value (9) Promotional Material (4) Samples & Gifts (2)
Therapy Area: All areas Other (360) Oncology (218) Cardiovascular (189) Respiratory (178) CNS & Neurology (169) Infectious Diseases (115) Diabetes (114) Rare Diseases (104) Immunology & Rheumatology (84) Dermatology (67) Obesity & Weight Management (63) Musculoskeletal & Bone (60) Ophthalmology (31)
Showing 720 results · Social Media & Digital  · Clear
🔒 Subscribers only
AUTH/3142/1/19
Social Media & Digital Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Sanofi
An anonymous complainant (professional status unknown) challenged an online advertisement/“advertorial” for Praluent (alirocumab) placed by Sanofi on the HSJ (Health Service Journal) website.Th…
Clauses: NONE
2019 🔒 Subscribe
🔒 Subscribers only
AUTH/3244/9/19
Social Media & Digital Not Upheld 🏥 Dermatology ▶ Video 🎙 Podcast
Leo Pharma
An anonymous, non-contactable complainant (stating they were a Leo Pharma employee) raised concerns about the dermatology Medical Scientific Liaison (MSL) team.Allegations included: MSLs ran promot…
Clauses: NONE
2019 🔒 Subscribe
🔒 Subscribers only
AUTH/3271/10/19
Social Media & Digital Not Upheld 🏥 Diabetes ▶ Video 🎙 Podcast
Napp
A UK health professional complained about Napp’s Invokana (canagliflozin) website, which had a landing page splitting users into a health professional area and a patient/general public area.The c…
Clauses: NONE
2019 🔒 Subscribe
🔒 Subscribers only
AUTH/3268/10/19
Social Media & Digital Not Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Merck Serono
A homecare services pharmacist complained about Merck Serono’s promotion of Mavenclad (cladribine) alongside a homecare dispense-and-deliver service and a patient support programme (adveva, inclu…
Clauses: NONE
2019 🔒 Subscribe
🔒 Subscribers only
AUTH/3270/10/19
Social Media & Digital Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Bayer
A UK health professional complained about Bayer’s UK website for Xarelto (rivaroxaban), a prescription only medicine.The landing page had two routes: one for UK healthcare professionals and one f…
Clauses: NONE
2019 🔒 Subscribe
🔒 Subscribers only
AUTH/3263/11/19
Social Media & Digital Not Upheld 🏥 Dermatology ▶ Video 🎙 Podcast
Almirall website claims for Ilumetri
An anonymous, non-contactable complainant challenged Almirall’s promotional website (Almirallmed.co.uk) for Ilumetri (tildrakizumab), alleging misleading dosing/efficacy claims and that POM promo…
Clauses: NONE
2019 🔒 Subscribe
🔒 Subscribers only
AUTH/3276/10/19
Social Media & Digital Not Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Ipsen
An anonymous, non-contactable complainant challenged a post on the Ipsen Global LinkedIn feed that referenced “positive first results” from the ENGAGE study in spastic hemiparesis.The post incl…
Clauses: NONE
2019 🔒 Subscribe
🔒 Subscribers only
AUTH/3272/10/19
Social Media & Digital Upheld 🏥 Infectious Diseases ▶ Video 🎙 Podcast
ViiV Healthcare breached Clause 28.1 after HCP website landing page did not clearly steer patients/p
A UK health professional complained about ViiV’s website “ViiV Exchange” (uk.viivexchange.com).The complaint alleged there was nothing to delineate between the general public, patients and he…
2019 🔒 Subscribe
🔒 Subscribers only
AUTH/3288/12/19
Social Media & Digital Not Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Biogen
An anonymous, non-contactable individual who said they worked in the NHS complained about a conversation at a social event (a wedding) between a Biogen Idec medical science liaison (MSL) and anothe…
Clauses: NONE
2019 🔒 Subscribe
🔒 Subscribers only
AUTH/3213/6/19
Social Media & Digital Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Janssen
An anonymous, non-contactable health professional complained about alleged off-licence promotion at a Janssen-sponsored oncology meeting (1–2 March 2019, London) titled “8th Prostate Cancer Sum…
Clauses: NONE
2019 🔒 Subscribe
🔒 Subscribers only
AUTH/3253/10/19
Social Media & Digital Upheld 🏥 Immunology & Rheumatology ▶ Video 🎙 Podcast
Celgene breached ABPI Code over Otezla BMJ “tile” ad missing PI link and separate certification (AUT
An anonymous UK health professional complained about an Otezla (apremilast) advertisement placed on bmj.com by Celgene Limited.The ad appeared as an “information tile” on a BMJ hosted-content p…
Clauses: 4.1,4.3,4.9
2019 🔒 Subscribe
🔒 Subscribers only
AUTH/3212/6/19
Social Media & Digital Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Otsuka UK/Otsuka Europe
An anonymous health professional complained about an online press release on ASTX727 (cedazuridine/decitabine fixed-dose combination) relating to the phase III ASCERTAIN study.The press release was…
Clauses: NONE
2019 🔒 Subscribe
🔒 Subscribers only
AUTH/3282/11/19
Social Media & Digital Upheld 🏥 Infectious Diseases ▶ Video 🎙 Podcast
Gilead Sciences Europe
What happened ViiV Healthcare UK Ltd alleged Gilead Sciences Europe Ltd breached an undertaking given in Case AUTH/3137/12/18 by continuing to use the claim that Biktarvy (bictegravir/emtrictabine/…
Clauses: 2,9
2019 🔒 Subscribe
🔒 Subscribers only
AUTH/3266/10/19
Social Media & Digital Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Otsuka UK/Otsuka Europe
A health professional complained about two online press releases concerning ASTX727 (oral cedazuridine/decitabine fixed-dose combination) being studied for MDS including CMML.Press release 1 (seen …
Clauses: NONE
2019 🔒 Subscribe
🔒 Subscribers only
AUTH/3227/7/19
Social Media & Digital Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Ferring v Pharmasure
Ferring complained about a Pharmasure Meriofert (menotrophin) detail aid (ref UK/201809/00001/01) and noted similar claims on the Pharmasure UK website (UK/201810/00005/01).The material compared Me…
Clauses: NONE
2019 🔒 Subscribe
🔒 Subscribers only
AUTH/3447/12/20
Social Media & Digital Upheld 🏥 Dermatology ▶ Video 🎙 Podcast
Sanofi
What happened Sanofi made a voluntary admission after discovering that material on www.dupixent.co.uk was not certified. The material was a Sanofi document referring to Dupixent (dupilumab) and NIC…
Clauses: 14.1
2019 🔒 Subscribe
🔒 Subscribers only
AUTH/3431/11/20
Social Media & Digital Not Upheld 🏥 Dermatology ▶ Video 🎙 Podcast
Allergan
What happened \n \n A doctor practising in aesthetics complained that Allergan employees had ‘liked’, commented on, and shared third-party social media posts (LinkedIn and Instagram) that refer…
Clauses: 2,26.1,9.1
2019 🔒 Subscribe
🔒 Subscribers only
AUTH/3502/4/21
Social Media & Digital Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Daiichi-Sankyo
What happened An anonymous complainant alleged Daiichi-Sankyo promoted three prescription-only medicines (olmesartan, prasugrel and edoxaban) to the public via a UK corporate website page. The page…
Clauses: 14.1,26.1,26.2,4.1,7.10,9.1
2019 🔒 Subscribe
🔒 Subscribers only
AUTH/3260/10/19
Social Media & Digital Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
GSK breached ABPI Code over broad QoL comparison claim for Trelegy Ellipta
A UK health professional complained about a Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) advertisement (ref UK/TLY/0035/17K) placed on the Primary Care Respiratory Society website …
Clauses: 9.1,26.1
2019 🔒 Subscribe
🔒 Subscribers only
AUTH/3267/10/19
Social Media & Digital Not Upheld 🏥 Other ▶ Video 🎙 Podcast
LEO Pharma
An anonymous, non-contactable individual (appearing to be a current employee) complained about LEO Pharma’s promotional practices. Allegations included: the same HCPs being invited to internation…
Clauses: NONE
2019 🔒 Subscribe
🔒 Subscribers only
AUTH/3204/6/19
Social Media & Digital Not Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
GlaxoSmithKline
An anonymous complainant (a concerned health professional employed by Otsuka, acting in a private capacity) alleged GlaxoSmithKline UK Limited’s public-facing website promoted prescription only m…
Clauses: NONE
2019 🔒 Subscribe
🔒 Subscribers only
AUTH/3273/10/19
Social Media & Digital Not Upheld 🏥 Immunology & Rheumatology ▶ Video 🎙 Podcast
Gedeon Richter website
A UK health professional complained about the online “Gedeon Richter Resource Centre”, described as providing training for health professionals and resources to use with patients.The complainan…
Clauses: NONE
2019 🔒 Subscribe
🔒 Subscribers only
AUTH/3265/10/19
Social Media & Digital Not Upheld 🏥 Other ▶ Video 🎙 Podcast
Bracco
A named complainant alleged Bracco employed representatives to sell medicines without ABPI qualifications and cited a named representative who had not sat/passed the ABPI medical representatives ex…
Clauses: NONE
2019 🔒 Subscribe
🔒 Subscribers only
AUTH/3230/7/19
Social Media & Digital Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
GSK breach over Zejula pipeline tweet on public Twitter feed (AUTH/3230/7/19)
A ‘concerned UK health professional’ complained about a tweet on GlaxoSmithKline’s global corporate Twitter channel (@GSK) that appeared in their feed.The tweet was part of a linked Q2 2019 r…
Clauses: NONE
2019 🔒 Subscribe
← Prev 15 16 17 18 19 20 21 Next → Page 18 of 30 — 720 cases
Unlock the Full Case Library
Annual subscription — instant access, cancel anytime.
🏆
The only PMCPA case library of its kind
No other provider publishes a structured, searchable library of PMCPA rulings with video and podcast. A single half-day compliance workshop from a specialist provider typically costs £499+ — for one session. Individual access here is £299 for a full year of 2,000+ cases.
PMCPA Case Library — Team (100 seats)
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
Enquire for bulk pricing →
Individual
For a single learner
£299
per year
Less than a single half-day workshop
  • 1 user seat
  • All 1752+ case studies
  • Video + podcast per case
  • MCQ quiz per case
  • 5 points per case passed
  • New cases added monthly
Create account or sign in to buy
Most Popular
Team 5
Up to 5 team members
£999
per year (£200/seat)
£200/person — the most cost-effective team option
  • 5 user seats
  • All case studies included
  • Video, podcast & MCQ per case
  • Team progress dashboard
  • New cases added monthly
  • Admin management portal
Create account or sign in to buy
Team 25+
25+ team members
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
  • 25 user seats
  • All case studies included
  • Video, podcast & MCQ per case
  • Team progress dashboard
  • Bulk seat management
  • Priority support
Enquire for bulk pricing →

Questions? Email [email protected]  ·  14-day money-back guarantee  ·  Annual subscription, auto-renews